Cervical hpv and tct screening are appropriate as long as they are performed during non-menstrual periods and the patient does not have acute inflammation of the reproductive tract, or vaginal medication for a short period of time. The hpv is a human papillomavirus test and the tct is a cervical exfoliative cytology test. Both are widely used in clinical practice for cervical screening and are usually sampled mostly at the same time. Cervical screening needs to be performed in the state of internal gynecological consultation, so it cannot be performed during menstruation. In addition, if a woman suffers from acute inflammatory diseases of the reproductive tract, such as vaginitis and endometritis, she may experience increased vaginal discharge. The stimulation of inflammatory secretions may lead to abnormal cervical exfoliation cell test results, making the test meaningless and also easily leading to aggravation of the existing inflammation. In addition, if a woman is using vaginally placed medications or has used them within a week, the medications may also cause abnormal test results. Therefore, if a woman wants to have a cervical hpv and tct test, she needs to know the timing in advance. In addition to avoiding menstruation, if there is inflammation of the reproductive tract, the test should be performed during the non-acute phase of inflammation; if there is vaginal medication, it should be stopped for more than 3 days to avoid affecting the test results.